TFO
Tarbox Family Office Portfolio holdings
AUM
$665M
1-Year Return
12.62%
This Quarter Return
+4.32%
1 Year Return
+12.62%
3 Year Return
+47.38%
5 Year Return
+83.96%
10 Year Return
+157.63%
AUM
$228M
AUM Growth
+$25.3M
(+12%)
Cap. Flow
+$17.4M
Cap. Flow
% of AUM
7.64%
Top 10 Holdings %
Top 10 Hldgs %
75.55%
Holding
641
New
39
Increased
281
Reduced
42
Closed
21
Top Buys
| 1 |
iShares Core S&P Small-Cap ETF
IJR
|
$20.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$5.38M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
$1.56M |
| 4 |
Schwab Fundamental International Large Company Index ETF
FNDF
|
$1.01M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
$785K |
Top Sells
| 1 |
Vanguard Small-Cap ETF
VB
|
$5.74M |
| 2 |
iShares Russell 2000 ETF
IWM
|
$4.62M |
| 3 |
iShares MSCI USA Quality Factor ETF
QUAL
|
$3.12M |
| 4 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
$1.87M |
| 5 |
DD
Du Pont De Nemours E I
DD
|
$295K |
Sector Composition
| 1 | Healthcare | 5.83% |
| 2 | Financials | 3.33% |
| 3 | Real Estate | 2.88% |
| 4 | Industrials | 2.12% |
| 5 | Consumer Staples | 1.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Newmont
NEM
$83.7B
| $11K | ﹤0.01% |
296
+27
| +10% | +$1K |
|
302
Occidental Petroleum
OXY
$45.2B
| $11K | ﹤0.01% |
177
+34
| +24% | +$2.11K |
|
303
Sempra
SRE
$52.9B
| $11K | ﹤0.01% |
200
| – | – |
|
304
Sysco
SYY
$39.4B
| $11K | ﹤0.01% |
211
+26
| +14% | +$1.36K |
|
|
RTN
305
DELISTED
Raytheon Company
RTN
| $11K | ﹤0.01% |
58
-737
| -93% | -$140K |
|
|
ENLK
306
DELISTED
EnLink Midstream Partners, LP
ENLK
| $11K | ﹤0.01% |
652
| – | – |
|
307
Expedia Group
EXPE
$26.6B
| $10K | ﹤0.01% |
66
+6
| +10% | +$909 |
|
308
Fortive
FTV
$16.2B
| $10K | ﹤0.01% |
172
+38
| +28% | +$2.21K |
|
309
Humana
HUM
$37B
| $10K | ﹤0.01% |
39
+6
| +18% | +$1.54K |
|
310
Public Storage
PSA
$52.2B
| $10K | ﹤0.01% |
47
+7
| +18% | +$1.49K |
|
311
Molson Coors Class B
TAP
$9.96B
| $10K | ﹤0.01% |
121
+10
| +9% | +$826 |
|
312
Agilent Technologies
A
$36.5B
| $9K | ﹤0.01% |
143
+20
| +16% | +$1.26K |
|
313
Quest Diagnostics
DGX
$20.5B
| $9K | ﹤0.01% |
99
+16
| +19% | +$1.46K |
|
314
Dover
DOV
$24.4B
| $9K | ﹤0.01% |
119
| – | – |
|
315
Leidos
LDOS
$23B
| $9K | ﹤0.01% |
155
| – | – |
|
316
Masco
MAS
$15.9B
| $9K | ﹤0.01% |
237
+44
| +23% | +$1.67K |
|
317
Omnicom Group
OMC
$15.4B
| $9K | ﹤0.01% |
125
-6
| -5% | -$432 |
|
318
Parker-Hannifin
PH
$96.1B
| $9K | ﹤0.01% |
50
+10
| +25% | +$1.8K |
|
319
Prologis
PLD
$105B
| $9K | ﹤0.01% |
147
+30
| +26% | +$1.84K |
|
320
Regeneron Pharmaceuticals
REGN
$60.8B
| $9K | ﹤0.01% |
21
+3
| +17% | +$1.29K |
|
321
Revvity
RVTY
$10.1B
| $9K | ﹤0.01% |
124
| – | – |
|
322
Truist Financial
TFC
$60B
| $9K | ﹤0.01% |
198
+49
| +33% | +$2.23K |
|
323
Travel + Leisure Co
TNL
$4.08B
| $9K | ﹤0.01% |
184
| – | – |
|
|
XLNX
324
DELISTED
Xilinx Inc
XLNX
| $9K | ﹤0.01% |
127
+17
| +15% | +$1.21K |
|
325
Edwards Lifesciences
EW
$47.5B
| $8K | ﹤0.01% |
213
+33
| +18% | +$1.24K |
|